CONMED Corp
CONMED Corporation (NYSE: CNMD) develops, manufactures and distributes medical devices and equipment for surgical procedures in orthopedics and general surgery, serving surgeons and other healthcare professionals as well as hospitals, surgery centers and other healthcare institutions. Its orthopedic products address… From the company’s description.
Over the twelve months to Sep 30, 2026, CONMED Corp reported revenue of $1.37B, up 1.6% from a year earlier, and net income of $73.43M. Its operating margin was 9.9%, and operations generated $146.31M in cash. In fiscal 2025, it reported revenue of $1.37B, up 5.2% from fiscal 2024, and net income of $47.05M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What CONMED Corp does
In the company’s own words
CONMED Corporation (NYSE: CNMD) develops, manufactures and distributes medical devices and equipment for surgical procedures in orthopedics and general surgery, serving surgeons and other healthcare professionals as well as hospitals, surgery centers and other healthcare institutions. Its orthopedic products address sports medicine and extremity procedures and include implants, fixation systems, power tools, fluid management and visualization equipment. General surgery offerings include insufflation, smoke evacuation, electrosurgery, endomechanical instruments, endoscopy devices and patient monitoring products. In 2025, orthopedic surgery accounted for 42% of net sales and general surgery for 58%; the company also reports international sales, with products sold in more than 100 countries. Net sales were approximately $1.37 billion in fiscal 2025, and CONMED had about 3,900 employees at year-end. Key brands include AirSeal, Buffalo Filter, Hall, Linvatec and BioBrace. Its website is http://www.conmed.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Electromedical Apparatus
- Headquarters
- LARGO, FL
- Fiscal year end
- December
- CIK
- 816956
- SIC
- 3845
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns CONMED Corp — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · CONMED Corp’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
CONMED Corp’s bonds, as funds hold them
Funds report holding 1 issues of CONMED Corp’s debt, $56.37M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 2.25%, maturing 2027 to 2027.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do CONMED Corp and its peers compare on margins and cash generation over ten years?”
- “Where did five years of CONMED Corp's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in CONMED Corp's last four quarterly filings that the numbers alone won't show?”